Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bath & Body Works Inc (BBWI) vs Verisign, Inc. (VRSN) Price & Performance

Bath & Body Works IncTrade
Verisign, Inc.Trade

Price performance (Past 24H)

Key statistics

Bath & Body Works Inc vs Verisign, Inc. — how do they compare? Bath & Body Works Inc trades at $20.43 (market cap $4.04B), while Verisign, Inc. trades at $268.99 (market cap $24.47B). The key difference: Verisign, Inc. is far larger — about 6.1× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays the higher dividend (3.99%). Which is the better fit depends on your goals.

BBWIVRSN
Market Cap
$4.04B$24.47B
Sector
Consumer CyclicalTechnology
52-Week High
$33.11$310.00
52-Week Low
$14.85$211.49
Enterprise Value
$7.93B$25.70B
Dividend Yield
3.99%1.21%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bath & Body Works Inc

BBWI trades at $20.42, up 0.44% today, with a bearish technical signal but attractive valuation metrics including a P/E of 5.8 and P/S of 0.58. Recent earnings show mixed quarterly beats, with Q1 2026 exceeding expectations. The company maintains solid profitability with a 10.03% net income margin and positive cash flow trends projected for 2026. Strategic initiatives include a new Ulta Beauty partnership and international expansion to drive growth amid declining revenue trends.

Outlook: BBWI presents a value opportunity with deep valuation discounts and operational strengths, though persistent revenue declines and high debt pose risks. Analyst consensus is cautiously optimistic with a $22 price target, suggesting modest upside potential if turnaround efforts gain traction against competitive and macroeconomic headwinds.

Verisign, Inc.

VeriSign (VRSN) trades at $270.31, up 0.07% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $1.66B, net income of $825.7M, and exceptional 49.96% net margin. Recent Q1 2026 earnings beat expectations at $2.34 EPS. Analyst consensus is bullish with 57% buy ratings and $327.67 price target, representing 21% upside potential. The company maintains its monopoly position in .com/.net domain registry with predictable revenue growth.

VRSN presents a compelling investment case with stable cash flows and dominant market position, though trading at premium valuations (P/E 29.87). Key risks include contract renewals, AI disruption potential, and high debt levels. The upcoming Q2 2026 earnings report on July 23 will be critical for validating growth trajectory. Current levels offer attractive entry for long-term investors seeking defensive tech exposure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bath & Body Works Inc

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.

Read more on BBWI

About Verisign, Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Read more on VRSN